Dr John Bartlett Literature Reviews Archives
PATIENT CIRCUMSTANCES AND HIV CARE
Hospitalized HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy (June 2009)
TRANSMISSION
HIV-1 Transmission, by Stage of Infection (September 2008)
EFFICACY & SAFETY
DUET-1 and DUET-2 Studies: Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients: 24-week results from a randomized, double-blind, placebo-controlled trial (July 2007)
Efficacy and safety of DRV/r compared with that of LPV/r at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomized controlled phase III trial (July 2007)
Decay of the HIV Reservoir in Patients Receiving ARV for Extended Periods: Implications for Eradication of Virus (June 2007)
HIV Suppression by HAART Preserves Cognitive Function in Advanced, Immune-reconstituted AIDS Patients (May 2007)
Prognosis of HIV-1-infected Patients up to 5 Years After Initiation of HAART: Collaborative Analysis of Prospective Studies (May 2007)
Efficacy and Safety of DRV-RTV at 48 Weeks in Treatment-Experienced HIV-infected Patients in POWER 1 and 2: A Subgroup Analysis of Data (April 2007)
Safety and Efficacy of the Integrase Inhibitor Raltegravir (MK-0518) in Treatment-Experienced Patients with Multidrug-Resistant Virus (April 2007)
Plasma HIV-1 RNA Dynamics in Antiretroviral-Naïve Subjects Receiving either Triple-Nucleoside or Efavirenz-Containing Regimens: ACTG A5166s (April 2007)
Evidence of Ongoing Immune Reconstitution in Subjects with Sustained Viral Suppression following 6 Years of Lopinavir-Ritonavir Treatment (March 2007)
CD4 Cell Count 6 Years after Commencement of HAART in Persons with Sustained Virologic Suppression (February 2007)
Tenofovir Disoproxil Furmarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in ARV-Naïve Patients: Virologic, Immunologic, and Morphologic Changes—A 96 Week Analysis (December 2006)
Viral Evolution and Future Drug Options in Heavily Pretreated Patients Receiving a Stable, Partially Suppressive Treatment Regimen (November 2006)
Updated Systematic Overview of Triple Combination Therapy in ARV-naïve HIV-infected Adults (October 2006)
HIV treatment response and prognosis in Europe and North America in the first decade of HAART: A collaborative analysis: The ART Cohort Collaboration (August 2006)
Three- vs Four-Drug ARV Regimens for the Initial Treatment of HIV-1 Infection (August 2006)
Immune Reconstitution Syndrome in HIV: Validating a Case Definition and Identifying Clinical Predictors in Persons Initiating Antiretroviral Therapy (June 2006)
EFFICACY/NOVEL DRUGS
HIV Type 1 Chemokine Coreceptor Use among ARV-Experienced Patients (February 2007)
ACUTE INFECTION
High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection (April 2007)
INITIATION OF THERAPY
When Should ARV Therapy for HIV Be Started? (January 2007)
ADHERENCE
Adherence to NNRTI-Based HIV Therapy and Virologic Outcomes (April 2007)
TREATMENT INTERRUPTION
CD4+ Count-Guided Interruption of Antiretroviral Treatment (June 2007)
Treatment Interruptions Predict Resistance in HIV+ Individuals Purchasing Fixed-dose Combination ARV Therapy in Kampala, Uganda (May 2007)
Nevirapine Clearance from Plasma in African Adults Stopping Therapy: A Pharmacokinetic Substudy (March 2007)
CD4-guided scheduled treatment interruptions compared with continuous therapy (August 2006)
SIDE EFFECTS/COMPLICATIONS
Cumulative HIV Viremia During HAART Is a Strong Predictor of AIDS-Related Lymphoma (July 2009)
Fungal Burden, Activity, and Outcome in Cryptococcal Meningitis in ARV-Naïve or ARV-Experienced Patients Treated with Amphotericin B or Fluconazole (July 2007)
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy (June 2007)
Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study (June 2007)
Chronic Renal Failure Among HIV-1-infected Patients (May 2007)
Class of ARV Drugs and the Risk of MI (April 2007)
Is the Increased Risk of Liver Enzyme Elevation in Patients Co-infected with HIV and Hepatitis Virus Greater in Those Taking ARV Therapy? (March 2007)
Metabolic Syndrome in HIV+ Patients from an Urban, Midwestern US Outpatient Population (March 2007)
Incidence and Natural History of Osteonecrosis in HIV-Infected Adults (March 2007)
SCREENING/TESTING
Rapid HIV Testing in Emergency Departments—Three U.S. Sites, January 2005—March 2006 (June 2007)
Home Testing to Detect Human Immunodeficiency Virus: Boon or Bane? (October 2006)
The WHO public-health approach to ARV treatment against HIV in resource-limited settings (August 2006)
Routine Screening: Informed Consent, Stigma and the Waning of HIV Exceptionalism (August 2006)
PREVENTION
Effectiveness of HIV Partner Counseling and Referral Services in Increasing Identification of HIV+ Individuals (August 2007)
Diaphragm and Lubricant Gel for Prevention of HIV Acquisition in Southern African Women: A Randomized Controlled Trial (July 2007)
Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-blind, Randomized, Placebo-Controlled Trial (May 2007)
Narrative Review: ARV Therapy to Prevent the Sexual Transmission of HIV-1 (April 2007)
Scientists Rethink Approach to HIV Gels (March 2007)
Circumcision for HIV Prevention in Rakai, Uganda (February 2007)
Circumcision for HIV Prevention in Kisumu, Kenya (February 2007)
MTCT
Response to ARV Therapy after a Single, Peripartum Dose of Nevirapine (January 2007)
TB
Impaired M. Tuberculosis-mediated Apoptosis in Alveolar Macrophages From HIV + Persons (July 2009)
Timing of ARV Therapy Initiation in TB Patients With AIDS: A Decision Analysis (February 2007)
Global Tuberculosis Control: WHO Report 2007 (January 2007)
XDRTB as a cause of death in HIV/TB coinfected patients in rural South Africa (November 2006)
HSV
Reduction of HIV-1 RNA Levels with Therapy to Suppress Herpes Simplex Virus (June 2007)
PCP
Reasons for Lack of Appropriate Receipt of Primary Pneumocystis jirovecii Pneumonia Prophylaxis among HIV-Infected Persons Receiving Treatment in the United States: 1994-2003 (March 2007)
Official ATS Workshop Summary: Recent Advances and Future Directions in PCP (November 2006)
DRUG RESISTANCE
HIV Drug Resistance Surveillance for Prioritizing Treatment in Resource-Limited Settings (May 2007)
ARV Drug Resistance, HIV-1 Tropism, and HIV-1 Subtype Among MSM with Recent HIV-1 Infection (May 2007)
Impact of Genotypic Drug Resistance Mutations on Clinical and Immunological Outcomes in HIV-infected Adults on HAART in West Africa (May 2007)
The Randomized Evaluation of Strategic Intervention in multi-drug resistant patients with TPV (RESIST) studies: An analysis of combined data from two randomized open-label trials (August 2006)
Tracking the Prevalence of Transmitted ARV Drug-Resistant HIV-1: A Decade of Experience (April 2006)
DISEASE PROGRESSION
Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal (April 2009)
Absolute Count and Percentage of CD4 Lymphocytes Are Independent Predictors of Disease Progression in HIV-Infected Persons Initiating HAART (February 2007)
HIV & STIs
Syphilis and HIV Infection: An Update (May 2007)
HIV/HCV COINFECTION
Care of Patients Coinfected with HIV and HCV: 2007 Updated Recommendations from the HCV-HIV International Panel (May 2007)
HIV & CANCER
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis (July 2007)
Facebook Twitter LinkedIn